ORGO

NASDAQStock

Organogenesis Holdings Inc.

$2.63-0.03 (-0.94%)

52-Week Range

$2.65
$6.54

Key Stats

Market Cap

337.7M

P/E Ratio

23.86

Dividend Yield

Beta

1.39

Volume

349.2K

Avg Volume

882.3K

Performance

1M

-29.14%

3M

-45.13%

6M

-46.57%

YTD

-42.83%

1Y

-47.11%

3Y

+22.69%

5Y

-84.59%

Price Chart

ETF Exposure

ORGO is held by 63 ETFs

ETFFund NameWeight
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
IWViShares Russell 3000 ETF0.00%
SCHBSchwab U.S. Broad Market ETF0.00%
VCNS.TOVanguard Conservative ETF Portfolio0.00%
VEQT.TOVanguard All-Equity ETF Portfolio0.00%
VRIF.TOVanguard Retirement Income ETF Portfolio0.00%
VTHRVanguard Russell 3000 ETF0.00%
VTIVanguard Total Stock Market ETF0.00%
VUN.TOVanguard U.S. Total Market Index ETF0.00%
VUS.TOVanguard U.S. Total Market Index ETF (CAD-hedged)0.00%
PreviousPage 2 of 2

About ORGO ETF Exposure

Organogenesis Holdings Inc. (ORGO) is held by 63 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 337.7M, ORGO is a widely held institutional stock. The stock currently trades at $2.63. Investors can gain exposure to ORGO through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ORGO, sorted by portfolio weight.